QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
QuantX Biosciences has raised $85.0M in total funding. The most recent round was Series B. The last funding was announced in February 2026.
QuantX Biosciences's investors include HSG, Lilly Asia Ventures, OrbiMed, Sanofi Ventures, Creacion Ventures.
QuantX Biosciences is headquartered in Princeton, United States.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
QuantX Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QuantX Biosciences — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/quantx-biosciences. Accessed November 12, 2026.
VCBacked. (2026). QuantX Biosciences — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/quantx-biosciences
{{cite web |title=QuantX Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/quantx-biosciences |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at QuantX Biosciences? Request a listing update